Literature DB >> 12406948

Antimicrobial resistance in Canada.

John Conly1.   

Abstract

Antibiotic resistance has increased rapidly during the last decade, creating a serious threat to the treatment of infectious diseases. Canada is no exception to this worldwide phenomenon. Data from the Canadian Nosocomial Infection Surveillance Program have revealed that the incidence of methicillin-resistant Staphylococcus aureus, as a proportion of S. aureus isolates, increased from 1% in 1995 to 8% by the end of 2000, and vancomycin-resistant enterococcus has been documented in all 10 provinces since the first reported outbreak in 1995. The prevalence of nonsusceptible Streptococcus pneumoniae in Canada in 2000 was found to be 12%. Human antimicrobial prescriptions, adjusted for differences in the population, declined 11% based on the total number of prescriptions dispensed between 1995 and 2000. There was also a 21% decrease in beta-lactam prescriptions during this same period. These data suggest that systematic efforts to reduce unnecessary prescribing of antimicrobials to outpatients in Canada, beginning after a national consensus conference in 1997, may be having an impact. There is, however, still a need for continued concerted efforts on a national, provincial and regional level to quell the rising tide of antibiotic resistance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406948      PMCID: PMC128402     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  62 in total

1.  The Garrod Lecture. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options.

Authors:  R C Moellering
Journal:  J Antimicrob Chemother       Date:  1991-07       Impact factor: 5.790

Review 2.  Antibiotic resistance: an ecological imbalance.

Authors:  S B Levy
Journal:  Ciba Found Symp       Date:  1997

3.  Use of antimicrobial agents and drug resistance.

Authors:  M N Swartz
Journal:  N Engl J Med       Date:  1997-08-14       Impact factor: 91.245

4.  Origin and molecular epidemiology of penicillin-binding-protein-mediated resistance to beta-lactam antibiotics.

Authors:  C G Dowson; T J Coffey; B G Spratt
Journal:  Trends Microbiol       Date:  1994-10       Impact factor: 17.079

Review 5.  Inactivation of antibiotics and the dissemination of resistance genes.

Authors:  J Davies
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

6.  The role of understaffing in central venous catheter-associated bloodstream infections.

Authors:  S K Fridkin; S M Pear; T H Williamson; J N Galgiani; W R Jarvis
Journal:  Infect Control Hosp Epidemiol       Date:  1996-03       Impact factor: 3.254

Review 7.  The epidemiology of enterococci.

Authors:  C Chenoweth; D Schaberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

Review 8.  Epidemiology and control of nosocomial infections in adult intensive care units.

Authors:  R A Weinstein
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

9.  Methicillin-resistant Staphylococcus aureus in Europe.

Authors:  A Voss; D Milatovic; C Wallrauch-Schwarz; V T Rosdahl; I Braveny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

10.  Agricultural use of antibiotics and the evolution and transfer of antibiotic-resistant bacteria.

Authors:  G G Khachatourians
Journal:  CMAJ       Date:  1998-11-03       Impact factor: 8.262

View more
  29 in total

1.  Antimicrobial resistance: A continuing Canadian tale.

Authors:  L E Nicolle
Journal:  Can J Infect Dis       Date:  2002-11

2.  The emergence of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in Canada.

Authors:  John M Conly; B Lynne Johnston
Journal:  Can J Infect Dis       Date:  2003-09

3.  A retrospective analysis of practice patterns in the treatment of methicillin-resistant Staphylococcus aureus skin and soft tissue infections at three Canadian tertiary care centres.

Authors:  John M Conly; H Grant Stiver; Karl A Weiss; Debbie L Becker; Andrew J Rosner; Elizabeth Miller
Journal:  Can J Infect Dis       Date:  2003-11

4.  Where are all the new antibiotics? The new antibiotic paradox.

Authors:  Jm Conly; Bl Johnston
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-05       Impact factor: 2.471

5.  Antimicrobial resistance - Judicious use is the key.

Authors:  John M Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-09       Impact factor: 2.471

6.  Canadian Committee on Antibiotic Resistance report.

Authors:  John M Conly; Scott McEwen; Jim Hutchinson; Nora Boyd; Sandra Callery; Elizabeth Bryce
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-09       Impact factor: 2.471

Review 7.  Antibiotic use and population ecology: how you can reduce your "resistance footprint".

Authors:  David M Patrick; James Hutchinson
Journal:  CMAJ       Date:  2009-02-17       Impact factor: 8.262

8.  Embracing ecology to limit antimicrobial resistance.

Authors:  Lindsay Nicolle; John M Conly; Noni MacDonald
Journal:  CMAJ       Date:  2009-02-17       Impact factor: 8.262

Review 9.  Antimicrobial resistance in hospitals: how concerned should we be?

Authors:  Michael R Mulvey; Andrew E Simor
Journal:  CMAJ       Date:  2009-02-17       Impact factor: 8.262

Review 10.  Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus.

Authors:  George G Zhanel; Grace Sniezek; Frank Schweizer; Sheryl Zelenitsky; Philippe R S Lagacé-Wiens; Ethan Rubinstein; Alfred S Gin; Daryl J Hoban; James A Karlowsky
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.